Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Breast Cancer
Interventions
DRUG

gefitinib

Trial Locations (8)

Unknown

Research Site, Århus C

Research Stie, Herlev

Research Site, København N

Research Site, København Ø

Research Site, Vejle

Research Site, Oslo

Research Site, Trondheim

Research Site, Lund

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY